Valuation: Cann Group Limited

Market Cap 8.3M 5.61M 5.09M 4.71M 4.25M 8.02M 526M 56.59M 22.42M 282M 21.03M 20.59M 895M P/E 2025
-0.24x
P/E 2026 0.34x
Enterprise Value 24.26M 16.38M 14.88M 13.75M 12.42M 23.44M 1.54B 165M 65.52M 825M 61.47M 60.17M 2.61B EV / Sales 2025
6.2x
EV / Sales 2026 2.51x
Free-Float
78.02%
Yield 2025 *
-
Yield 2026 -
1 day+10.00%
1 week+10.00%
Current month+10.00%
1 month+37.50%
3 months+83.33%
6 months+10.00%
Current year-38.89%
1 week 0
Extreme 0.005
0.01
1 month 0
Extreme 0.004
0.01
Current year 0
Extreme 0.002
0.01
1 year 0
Extreme 0.002
0.01
3 years 0
Extreme 0.002
0.19
5 years 0
Extreme 0.002
0.44
10 years 0
Extreme 0.002
4.55
Manager TitleAgeSince
Director of Finance/CFO - 14/08/2024
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2018
Director TitleAgeSince
Chairman 79 10/02/2025
Director/Board Member 59 31/03/2025
Chairman - 01/12/2025
Date Insider Type Main position Quantity % Market Cap. Importance
6/12/24 A Buy

Chief Executive Officer

205,500 0.0469%
8/1/23 A Buy

Director

165,515 0.0341%
8/1/23 A Buy

Chairman

284,091 0.0585%
Change 5-day change 1-year change 3-year change Capi.($)
+10.00%+10.00%-50.00%-95.00% 5.61M
-3.58%+3.92%+13.85%+29.80% 113B
+0.25%+1.36%+8.28%+112.87% 107B
+0.61%-9.96%+41.22%+446.26% 41.83B
-0.06%+2.67%+10.55%+101.27% 33.39B
-0.17%+0.17%+39.56%+76.75% 30.24B
-0.40%+0.98%+40.26%+94.33% 28.85B
+0.51%+0.88%+51.13%+401.44% 23.2B
+0.33%-1.21%-17.53%-18.49% 19.72B
0.00%+2.84%-2.93%+33.78% 17.18B
Average +0.58%+0.01%+13.44%+118.30% 41B
Weighted average by Cap. -1.12%+0.68%+18.52%+125.56%

Financials

2025 2026
Net sales 13.25M 8.95M 8.13M 7.51M 6.78M 12.8M 840M 90.32M 35.79M 451M 33.57M 32.86M 1.43B 9.65M 6.52M 5.92M 5.47M 4.94M 9.33M 612M 65.79M 26.07M 328M 24.45M 23.94M 1.04B
Net income -22.34M -15.09M -13.71M -12.66M -11.44M -21.59M -1.42B -152M -60.34M -760M -56.61M -55.41M -2.41B 20.62M 13.92M 12.65M 11.69M 10.56M 19.92M 1.31B 141M 55.69M 702M 52.25M 51.14M 2.22B
Net Debt 75.83M 51.19M 46.51M 42.97M 38.82M 73.25M 4.81B 517M 205M 2.58B 192M 188M 8.17B 15.96M 10.78M 9.79M 9.05M 8.17M 15.42M 1.01B 109M 43.1M 543M 40.44M 39.58M 1.72B
Projected Income Statement - Annual - Cann Group Limited
Logo Cann Group Limited
Cann Group Limited is an Australia-based company, which is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the Company, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. It operates through cultivation of the medicinal cannabis segment. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research and good manufacturing practices (GMP) manufacturing facilities are near Mildura, Victoria.
Employees
-
Date Price Change Volume
17/11/26 A$0.005500 +10.00% 330,839
16/11/26 A$0.005000 0.00% 4,629,927
13/11/26 A$0.005000 -9.09% 1,027,835
12/11/26 A$0.005500 +10.00% 51,999
11/11/26 A$0.005000 0.00% 570,873